Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC)
Publication
, Conference
Nelson, JB; Fizazi, K; Miller, K; Higano, CS; Moul, JW; Morris, T; McIntosh, S; Pemberton, K; Gleave, ME
Published in: JOURNAL OF CLINICAL ONCOLOGY
March 1, 2011
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
March 1, 2011
Volume
29
Issue
7
Publisher
AMER SOC CLINICAL ONCOLOGY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Nelson, J. B., Fizazi, K., Miller, K., Higano, C. S., Moul, J. W., Morris, T., … Gleave, M. E. (2011). Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 29). AMER SOC CLINICAL ONCOLOGY.
Nelson, J. B., K. Fizazi, K. Miller, C. S. Higano, J. W. Moul, T. Morris, S. McIntosh, K. Pemberton, and M. E. Gleave. “Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 29. AMER SOC CLINICAL ONCOLOGY, 2011.
Nelson JB, Fizazi K, Miller K, Higano CS, Moul JW, Morris T, et al. Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC). In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2011.
Nelson, J. B., et al. “Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC).” JOURNAL OF CLINICAL ONCOLOGY, vol. 29, no. 7, AMER SOC CLINICAL ONCOLOGY, 2011.
Nelson JB, Fizazi K, Miller K, Higano CS, Moul JW, Morris T, McIntosh S, Pemberton K, Gleave ME. Phase III study of the efficacy and safety of zibotentan (ZD4054) in patients with bone metastatic castration-resistant prostate cancer (CRPC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2011.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
March 1, 2011
Volume
29
Issue
7
Publisher
AMER SOC CLINICAL ONCOLOGY
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences